Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.21.1
Stock Based Compensation (Details)
 3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Number of shares  
Number of shares, Beginning balance 16,218,326
Number of shares, Grants 0
Number of shares, Expiration 0
Number of shares, Ending balance 16,218,326
Options exercisable, Ending balance 16,093,326
Weighted Average Exercise Price  
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.50
Weighted Average Exercise Price, Ending balance | $ / shares 0.50
Options exercisable, Ending balance | $ / shares $ 0.50
Weighted Average Remaining Contractual Life (years)  
Weighted Average Remaining Contractual Life (years), Beginning balance 3 years 6 months 26 days
Weighted Average Remaining Contractual Life (years), Ending balance 3 years 3 months 26 days
Options exercisable, Ending balance 3 years 3 months 22 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value, Beginning balance | $ $ 3,588,631
Aggregate Intrinsic Value, Ending balance | $ 10,965,344
Options exercisable, Ending balance, Intrinsic value | $ $ 10,842,844